Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
CNS innovator oligonucleotide licensing value surges by 339% to $2.8 billion in 2024, reveals…
GlobalData attributes surge in CNS oligonucleotide licensing to increased adoption of ASOs and siRNAs, alongside advancements in…
Rubicon Research acquires Alkem’s Pithampur manufacturing facility for ₹149 crores
The acquisition expands Rubicon’s manufacturing footprint and capabilities in high-potency formulations, supporting its US market…
Glenmark launches TEVIMBRA in India for treatment of advanced lung and oesophageal cancer
Glenmark Pharmaceuticals introduces tislelizumab following CDSCO approval, expanding its oncology portfolio with its first…
CORONA Remedies appoints four independent directors to strengthen board governance
Ameetkumar H Desai, Bhaskar V Iyer, Shirish G Belapure, and Monica H Kanuga join CORONA Remedies’ Board as Independent Directors…
Why most extractables & leachables studies fail regulatory review-and how to fix them
Madhu of SG Pharma Solutions highlights why extractables and leachables (E&L) studies frequently fail regulatory review and…
CII to host ‘Pillars of Protection’ conference in Hyderabad to address safety in pharma…
The event will highlight collaborative approaches to risk management, compliance, and technology integration for safer…
Eli Lilly shares results from QWINT trials on once-weekly insulin efsitora for type 2 diabetes
Efsitora met primary endpoints across three Phase 3 trials, showing comparable glucose control to daily basal insulin therapies
Addressing US FDA challenges in Indian sterile drug manufacturing – Part 3
In this final instalment, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech, transitions from analysis to action. Drawing on…
Addressing US FDA challenges in Indian sterile drug manufacturing – Part 2
In this second part, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech continues the discussion on FDA expectations, with…
Biopharma innovation meets market headwinds tempering optimism: GlobalData
GlobalData’s report captures a moment for the global biopharmaceutical sector, where the pace of innovation is clashing with a…